Matinas BioPharma Holdings (MTNB) Research & Development (2013 - 2025)
Matinas BioPharma Holdings (MTNB) recorded Research & Development of $85,000 in FY2025, down 99.3% from $11.43 million in FY2024.
Powered by 
Analysis
Matinas BioPharma Holdings (MTNB) Research & Development (2013 - 2025) Analysis & Trends
Starting with FY2013, Matinas BioPharma Holdings' Research & Development history includes 13 years.
- Annual Research & Development has declined for three straight years, with a five-year compound annual growth rate of -64.2% (FY2020 to FY2025).
- The FY2025 figure is the lowest annual Research & Development in data going back to FY2013.
- Per Business Quant data, MTNB's Research & Development was $11.43 million in FY2024 (-21.1%), $14.49 million in FY2023 (-13.1%), $16.68 million in FY2022 (+14.4%) and $14.58 million in FY2021 (+1.6%).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | R&D (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,167.17 Bn | 1,135.76 Bn | 19.71 Bn | 3.82 Bn |
| 2 | Johnson & Johnson | 633.70 Bn | 552.23 Bn | 17.26 Bn | 3.65 Bn |
| 3 | AbbVie | 503.94 Bn | 477.06 Bn | 12.70 Bn | 2.34 Bn |
| 4 | Merck | 378.10 Bn | 332.47 Bn | 12.21 Bn | 9.74 Bn |
| 5 | Novartis Ag | 303.72 Bn | 267.71 Bn | 11.24 Bn | 2.85 Bn |
| 6 | Astrazeneca | 266.46 Bn | 240.15 Bn | 12.86 Bn | 4.05 Bn |
| 7 | Amgen | 241.07 Bn | 196.47 Bn | 7.24 Bn | 1.87 Bn |
| 8 | Gilead Sciences | 194.22 Bn | 168.41 Bn | 6.22 Bn | 1.76 Bn |
| 9 | Pfizer | 172.39 Bn | 119.04 Bn | 10.94 Bn | 2.81 Bn |
| 10 | Matinas BioPharma Holdings | 653,430.86 | -11.94 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Mar 31, 2025 | 85,000.00 |
| Dec 31, 2024 | 2.38 Mn |
| Sep 30, 2024 | 2.24 Mn |
| Jun 30, 2024 | 3.37 Mn |
| Mar 31, 2024 | 3.45 Mn |
| Dec 31, 2023 | 3.67 Mn |
| Sep 30, 2023 | 3.30 Mn |
| Jun 30, 2023 | 3.56 Mn |
| Mar 31, 2023 | 3.97 Mn |
| Dec 31, 2022 | 3.87 Mn |
| Sep 30, 2022 | 3.71 Mn |
| Jun 30, 2022 | 4.13 Mn |
| Mar 31, 2022 | 4.98 Mn |
| Dec 31, 2021 | 4.24 Mn |
| Sep 30, 2021 | 4.62 Mn |
| Jun 30, 2021 | 2.48 Mn |
| Mar 31, 2021 | 3.24 Mn |
| Dec 31, 2020 | 3.53 Mn |
| Sep 30, 2020 | 3.34 Mn |
| Jun 30, 2020 | 3.41 Mn |
API Access
Matinas BioPharma Holdings Research & Development API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=research-and-development&ticker=MTNB&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "research-and-development", "ticker": "MTNB", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=research-and-development&ticker=MTNB&period=max&api_key=YOUR_API_KEY");
const data = await res.json();